← Back to Search

SBIRT for Smoking Cessation

N/A
Waitlist Available
Led By E. Melinda Mahabee-Gittens, MD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6months post enrollment
Awards & highlights

Study Summary

This trial will test whether a cessation intervention can help caregivers who smoke and whose children have Second Hand Smoke exposure-related illnesses.

Eligible Conditions
  • Smoking Cessation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6months post enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6months post enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants With Self-reported Prolonged Abstinence at 6 Months
Percentage of Participants With Self-reported Prolonged Abstinence at 6 Weeks
Secondary outcome measures
Change From Baseline in the Number of Cigarettes Smoked Per Day at 6 Months
Smoke
Number of Quit Attempts at 6 Months
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SBIRTExperimental Treatment1 Intervention
An assessment form, motivational interviewing, personalized educational materials, immediate access to cessation resources, a 12-week supply of nicotine replacement therapy and weekly booster materials for 12 weeks. nicotine
Group II: HHCPlacebo Group1 Intervention
The Healthy Habits Control program has been previously developed and used in the out-patient setting, and will be used as an attention control in which caregivers will receive instruction on healthy lifestyle choices to improve their child's health. Cessation assistance will be offered at the study's conclusion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SBIRT
2012
Completed Phase 2
~4990

Find a Location

Who is running the clinical trial?

National Institute of Environmental Health Sciences (NIEHS)NIH
284 Previous Clinical Trials
1,231,967 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,530,826 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,963 Previous Clinical Trials
2,673,971 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the objectives of this investigation?

"The primary focus of this investigation, evaluated over 6 weeks post enrollment, is to evaluate the proportion of participants expressing prolonged abstinence at 6 months. Secondary objectives include measuring readiness to quit with the Contemplation Ladder score and analysing use of cessation resources after both six-week and six-month intervals."

Answered by AI

Are there still opportunities to join this investigation?

"As indicated on clinicaltrials.gov, the recruitment phase of this research project has concluded; it was initially posted in April 2016 and last updated in October 2022. Nevertheless, there are still 329 other studies that are currently welcoming participants."

Answered by AI
Recent research and studies
~86 spots leftby Apr 2025